News
-
-
PRESS RELEASE
Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
Laxxon Medical announces development program for LXM.2, a 3D printed oral GLP-1 receptor agonist for obesity treatment, offering an alternative to injections. Utilizes SPID® platform technology for enhanced bioavailability -
-
-
-
PRESS RELEASE
Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024
Laxxon Medical to participate in World Orphan Drug Congress USA 2024. Dr. Catherine Gatza to represent the Company at the event in Boston, Massachusetts. Company leveraging SPID®-Technology for pharmaceutical advancements -
-
PRESS RELEASE
Laxxon Medical to Participate in 23rd Annual Needham Virtual Health Conference
Laxxon Medical to participate in the 23rd Annual Needham Virtual Health Conference. CEO/Chairman and Chief Strategy Officer will engage with investors. Company focuses on advanced pharmaceuticals with innovative technology -
PRESS RELEASE
Laxxon Medical to Attend BIO-Europe Munich 2023
-
-
Alset Capital Inc. Announces AI GPU Contract with a $91.7M Option Signed by Investee Company Cedarcross
-
Ivanhoe Electric Clarifies Certain Misleading Media Headlines Regarding Its Recent Registration Statement Filing
-
FE Battery Metals Announces Positive Laboratory Results Producing Lithium Carbonate Grades Exceeding 99% Purity
-
SouthGobi Announces Update on Mongolia Tax Audit
-
Perk Labs Announces Non-Brokered Private Placements
-
TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
-
German Software Company comforte AG Receives International Award: Excellence in Cybersecurity for Banks and Payment Service Providers
-
NET DIGITAL AG launches innovative AI product airis:ident for fully automated and legally compliant identity verification worldwide
-
EQS-Adhoc: MEDION AG: Lenovo Germany Holding GmbH submits request for transfer of the shares held by the minority shareholders of MEDION AG (squeeze-out under German stock corporation law)
-
Nordex exceeds 5 GW threshold for installations in the Nordics
-
Moody’s reaffirms « A1 » Outlook Stable rating of CNP Assurances SA
-
EURAZEO OPENS AN OFFICE IN TOKYO, FURTHER EXTENDING ITS INTERNATIONAL REACH
-
imerys-12-06-2024-implementation-of-the-share-buyback-program
-
COGELEC : Statement on the total number of shares and voting rights.
-
Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens